Phytotherapy Research, a distinguished journal published by Wiley, stands at the forefront of the pharmacological literature, delivering essential insights into the therapeutic potential of plant-based interventions. With its ISSN 0951-418X and E-ISSN 1099-1573, the journal has firmly established itself since its inception in 1987, now converging into its 2024 volume. Notably positioned in the Q1 category of Pharmacology and ranked #22 out of 313 journals in the field, it boasts a remarkable 93rd percentile rating according to Scopus. While the journal adheres to subscription-based access, it remains a crucial repository of high-quality research findings that support the understanding and advancement of herbal medicines and phytotherapeutics. This journal serves as an invaluable resource for researchers, healthcare professionals, and students alike, fostering a deeper exploration of the synergistic relationship between nature and medicine and promoting evidence-based practices in the field.

BIOFACTORS, an esteemed journal published by Wiley, serves as a pivotal resource in the fields of Biochemistry, Clinical Biochemistry, and Molecular Medicine. With ISSN 0951-6433 and E-ISSN 1872-8081, the journal has established its reputation since its inception in 1988, showcasing a rich history of scientific inquiry and innovation. Recognized for its high academic standards, it currently holds a Q1 ranking in key categories, including Biochemistry and Medicine (miscellaneous), and ranks in the top 10% for Clinical Biochemistry according to Scopus metrics, reflecting its impact and influence in the scientific community. Although it does not offer Open Access, BIOFACTORS provides researchers the opportunity to publish and disseminate high-quality studies that advance our understanding of biological factors and their clinical implications. The journal actively encourages contributions that bridge the gap between laboratory findings and clinical applications, making it a vital platform for both seasoned researchers and emerging scholars in the life sciences.

JOURNAL OF HERBS SPICES AND MEDICINAL PLANTS, published by Taylor & Francis Ltd, serves as a pivotal platform for researchers and professionals in the fields of Complementary and Alternative Medicine and Pharmacology. With an ISSN of 1049-6475 and E-ISSN of 1540-3580, this journal is dedicated to advancing the understanding of the therapeutic potential of herbs, spices, and various medicinal plants, and showcases high-quality, peer-reviewed research from 1992 to 2024. As of 2023, it holds a respectable Q3 ranking in both relevant categories, exhibiting its growing influence within the academic community. The journal is not open access, yet it remains a vital resource for those exploring the diverse applications and efficacy of plant-based therapies. Researchers and students alike will benefit from the journal’s commitment to disseminating innovative findings that can enhance the quality of life through natural remedies, thereby contributing significantly to the global discourse on herbal medicine.

INTERNATIONAL JOURNAL OF MEDICINAL MUSHROOMS, published by Begell House Inc, stands as a pivotal resource in the realm of mycology and its applications in health and medicine. With an ISSN of 1521-9437 and an E-ISSN of 1940-4344, this journal has carved a niche for itself since its inception in 2005, converging knowledge and research through 2024 and beyond. Renowned for its dedication to advancing the understanding of medicinal mushrooms, this journal is categorized in the third quartile across multiple categories, including Applied Microbiology and Biotechnology, Drug Discovery, and Pharmacology, indicating its relevance in these critical scientific fields. Though it operates under a traditional subscription model, the journal's emphasis on quality research makes it an essential read for researchers, professionals, and students seeking comprehensive insights into the therapeutic potential of fungi. As the landscape of pharmacology and biotechnology expands, the INTERNATIONAL JOURNAL OF MEDICINAL MUSHROOMS remains a cornerstone for innovative exploration and discovery in the application of mushrooms within medicine.

INFLAMMOPHARMACOLOGY is a premier journal published by SPRINGER BASEL AG, specializing in the evolving fields of immunology and pharmacology. Established in 1991, the journal has made significant strides in contributing to the understanding of inflammation-related disorders, therapeutic innovations, and the pharmacological implications associated with these conditions. With an impressive Q2 ranking in Immunology and Q1 rankings in both Pharmacology and Medical Pharmacology for 2023, alongside notable Scopus rankings, INFLAMMOPHARMACOLOGY maintains its position at the forefront of scientific research. The journal provides a vital platform for researchers and practitioners to disseminate groundbreaking findings and explore novel approaches in therapeutics, reinforcing the importance of evidence-based medicine. Accessible exclusively through traditional subscription options, it continues to attract a diverse readership invested in advancing knowledge within these cutting-edge disciplines.

Zeitschrift für Arznei- & Gewürzpflanzen, published by AGRIMEDIA GMBH in Germany, serves as a vital platform for the dissemination of research in the fields of agronomy, food science, and plant science. With an ISSN of 1431-9292, this journal focuses on the study and application of medicinal and aromatic plants, making significant contributions to both academia and industry. Although it is classified in Q4 quartiles across its relevant fields for 2023 and has a Scopus ranking that places it in the lower percentiles, the journal offers a crucial resource for understanding the ongoing developments and research challenges in herbal medicine and crop enhancement. It aims to provide a comprehensive view on various aspects of herbal studies, including cultivation, pharmacological properties, and their implications for food science, thus appealing to researchers, professionals, and students involved in plant research, agriculture, and nutrition. For access information, please refer to the journal's official web portal for details on subscription and submission guidelines.

Fitoterapia is a prestigious journal published by Elsevier that specializes in the fields of drug discovery and pharmacology. Established in 1948 and featuring a comprehensive scope that encompasses all aspects of medicinal plants and their derivatives, this journal is a critical resource for researchers, professionals, and students interested in the pharmacological effects of natural products. With an impressive impact factor reflected in its Q2 ranking in both Drug Discovery and Medicine as well as a Q3 ranking in Pharmacology, Fitoterapia plays a vital role in promoting innovative research in the intersection of traditional medicine and modern pharmacological science. The journal’s commitment to quality is further highlighted by its rankings in Scopus, where it holds a notable position among peers in its field. Although Fitoterapia does not currently offer Open Access, its reputation for rigor and relevance makes it an indispensable asset for anyone engaged in herbal medicine research and development. Authors and researchers seeking to publish groundbreaking findings will find a welcoming platform to disseminate their work in this influential journal.

Annals of Phytomedicine - An International Journal is a leading publication dedicated to the exploration and advancement of phytomedicine, broadly encompassing research on medicinal plants, their bioactive compounds, and therapeutic applications. Published by UKAAZ Publications, this journal seeks to bridge the gap between traditional and modern medicinal practices, offering a platform for researchers, professionals, and students passionate about herbal therapies and their efficacy. With an ISSN 2393-9885 and E-ISSN 2278-9839, the journal adheres to stringent peer-review protocols to ensure the publication of high-quality research. Fostering open access to knowledge in a rapidly evolving field, Annals of Phytomedicine serves as an essential resource, promoting innovative findings and comprehensive reviews that drive the global discourse on phytotherapy. By engaging with this journal, readers can stay informed about the latest advancements, contributing significantly to the scholarly community and beyond.

TAXON is a premier international journal published by Wiley, dedicated to the fields of ecology, evolution, behavior, systematics, and plant science. With a distinguished history since 1970 and a commitment to advancing knowledge in the biological sciences, TAXON has been recognized in the Q1 category for both its ecological and plant science contributions as of 2023. The journal boasts an impressive Scopus ranking, placing it in the 76th percentile for Ecology, Evolution, Behavior and Systematics and the 74th percentile for Plant Science, highlighting its significance and impact within these domains. While not an open-access publication, TAXON offers a wealth of high-quality research articles, reviews, and discussions, making it an indispensable resource for researchers, professionals, and students alike seeking to deepen their understanding of biodiversity and systematics. For access to its cutting-edge research, readers can follow the journal's updates and contributions online.

Natural Product Communications is an esteemed open-access journal published by SAGE Publications Inc, dedicated to the exploration and dissemination of knowledge concerning natural products in diverse fields, including Complementary and Alternative Medicine, Drug Discovery, and Pharmacology. Since its inception in 2006 and continuing through its converged years until 2024, the journal has gained recognition with a robust focus on plant science and the medicinal properties of natural products. With a commendable impact factor reflected in its category quartiles (Q3 across key domains), Natural Product Communications serves as a vital resource for researchers and professionals who aim to further the understanding of the therapeutic potential of natural compounds. As an open-access journal since 2020, it ensures wide accessibility to its published research, thereby facilitating collaboration and innovation within the scientific community. This commitment to excellence makes Natural Product Communications a crucial platform for advancing research in the holistic and pharmacological sciences.